Definitive Contract 80ARC022CA004

Award Date 9/28/22
Potential Completion Date 9/29/26
Potential Value $2M
Contracting Federal Agency
Ames Research Center
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10029, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
9
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution in New York City. The contract, valued at $399,266.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to support the development of animal models of infectious diseases. The award is a delivery order under NIAID's larger "Animal Models of Infectious Diseases...
This is a $324,000.00 definitive, firm-fixed price contract awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to the Icahn School of Medicine at Mount Sinai (ISMMS), a private, non-profit educational institution. The contract, titled "BRAIN BANK," does not have a small business set-aside designation. The contract requires ISMMS to provide specialized services and research related to a brain bank over a period ending on...
This federal contract award, with an ID of 75N95019C00049, was made by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian agency. The purpose of the $15,570,280.46 cost-no-fee definitive contract is to establish collection site(s) (i.e., the NIH Brain and Tissue Repository (NBTR)) to provide services that will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and related...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private university and non-profit educational institution. The $10,799,605.00 Definitive Contract is for BIOMEDICAL (BASIC) services, with a Firm Fixed Price pricing type. The contract has no set-aside designation and was awarded on August 17, 2009, with a completion date of September...
This is a definitive contract awarded by the Department of the Army's Research, Development and Engineering Command (RDECOM) to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution located in New York City. The contract, valued at $1,041,139.74, was awarded on February 1, 2024, and has a completion date of February 28, 2025. The purpose of this contract is to develop and standardize an assay for evaluating immunomodulatory activities of...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private academic medical center and research institution located in New York, NY. The $18,691,713.00 cost-no-fee definitive contract is for biomedical research services, with a period of performance ending on March 31, 2011. The contract does not have a set-aside designation....
The National Institute of Mental Health (NIMH) awarded a $15,926,648.00 cost-no-fee definitive contract to the Icahn School of Medicine at Mount Sinai (ISMMS) to operate the National NeuroHIV Tissue Consortium (NNTC) Clinical Sites. The NNTC collects, stores, and provides clinical data and well-characterized biological specimens, including post-mortem tissue, from study volunteers and organ donors with HIV as well as HIV-negative controls. This contract supports NIMH's mission to transform the...
This firm-fixed-price purchase order, awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services, provides for a study of biospecimens from the Norwegian Mother and Child Cohort Study (MOBA). The $50,000.00 contract was awarded to the Icahn School of Medicine at Mount Sinai (ISMMS), a private, non-profit educational institution, on September 19, 2017, with a final completion date of March 16, 2022. This...
This federal contract award is for the "MODELING IMMUNITY FOR BIODEFENSE" program, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS), a private non-profit educational institution. The award is a $23,517,489.00 definitive contract with a cost-no-fee pricing type, with a period of performance from September 29, 2005 to September 29, 2010. The contract does not have a set-aside designation. ISMMS, a renowned...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Icahn School of Medicine at Mount Sinai (ISMMS) to provide World Trade Center Health Program Clinical Center of Excellence services. The contract has a total ceiling value of $129,501,824.39 and runs through September 30, 2022. The contract is not set aside for any special designation. ISMMS, a private university and non-profit organization, is providing specialized medical services and...

This is a definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Icahn School of Medicine at Mount Sinai (ISMMS) for the "Identification of Biomarkers and Pathological Mechanisms via Longitudinal Analysis of Neurological and Cerebrovascular Responses to Neurotoxic Stress Using a Multi-Cellular Integrated Model of the Human Brain." The contract has a ceiling value of $1,992,983.20 and a period of performance through September 29, 2026. ISMMS is a private, non-profit university and research institution that has a strong track record of federal contract and grant awards, particularly in the areas of medical research, clinical studies, and translational science. This contract supports the development of advanced models and technologies to study the effects of neurotoxic stressors on the human brain, which aligns with NCATS' mission to accelerate the translation of scientific discoveries into clinical applications. The contract was not set aside for any specific business type.

Generated 4/30/25, 10:21 AM